Keros Therapeutics Inc. (KROS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Keros Therapeutics Inc.

    NASDAQ: KROS · Real-Time Price · USD
    15.59
    0.04 (0.26%)
    At close: Sep 05, 2025, 3:59 PM
    15.59
    0.00%
    After-hours: Sep 05, 2025, 04:10 PM EDT

    Keros Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 559.93M 331.15M 279.05M 230.04M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 1.45M 1.21M 1.33M 1.33M
    Other Long-Term Assets
    		 2.06M 2.05M 2.12M 82K
    Receivables
    		 4.46M 1.09M 841K 18M
    Inventory
    		 n/a n/a -841K 3.06M
    Other Current Assets
    		 1.48M 1M 180K 340K
    Total Current Assets
    		 588.89M 347.29M 285.77M 251.44M
    Property-Plant & Equipment
    		 23.49M 19.47M 17.57M 2.4M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 26.99M 22.73M 21.01M 3.81M
    Total Assets
    		 615.89M 370.02M 306.78M 255.25M
    Account Payables
    		 4.6M 5.45M 3.34M 3.65M
    Deferred Revenue
    		 n/a n/a n/a 7.13M
    Short-Term Debt
    		 n/a n/a 455K 862K
    Other Current Liabilities
    		 10.55M 10.38M 7.49M 3.99M
    Total Current Liabilities
    		 27.45M 24.37M 16.55M 11.85M
    Long-Term Debt
    		 n/a n/a 12.81M 231K
    Other Long-Term Liabilities
    		 n/a n/a -12.81M -231K
    Total Long-Term Liabilities
    		 16.88M 13.44M 12.81M 231K
    Total Liabilities
    		 44.33M 37.81M 29.36M 12.08M
    Total Debt
    		 18.86M 14.44M 13.27M 1.09M
    Common Stock
    		 4K 3K 2K 2K
    Retained Earnings
    		 -568.78M -381.43M -228.43M -123.75M
    Comprehensive Income
    		 n/a 0.00 -0.00 -0.00
    Shareholders Equity
    		 571.55M 332.21M 277.42M 243.17M
    Total Investments
    		 1.45M 1.21M 1.33M 1.33M

    Add to Watchlist